Kala Bio Deploys Bionic Intelligence Agent for Biotech with 70B-Parameter AI Model
Kala Bio has commercially launched its Bionic Intelligence Research Agent on March 30, delivering its first purpose-built agentic AI solution through its Researgency.ai platform within the promised 14-day window. Powered by a 70-billion-parameter model, BIRA offers secure, VPN-only enterprise deployment for biotechnology and pharmaceutical research.
1. Commercial Launch of Bionic Intelligence Research Agent
On March 30, Kala Bio commercially deployed its first purpose-built agentic AI solution, the Bionic Intelligence Research Agent (BIRA), within the Researgency.ai platform under its exclusive worldwide license with Younet. This achievement fulfilled the company's commitment to ship its inaugural AI agent within 14 days, marking its transition to live enterprise deployment.
2. Enterprise-Grade Security and Scalable Infrastructure
BIRA operates solely within client-controlled VPN-secured environments, ensuring full data sovereignty and compliance with pharmaceutical R&D standards through complete audit trails and minimal cloud latency. Powered by a 70-billion-parameter language model, the platform offers autonomous multi-step query decomposition, cross-source synthesis, and pre-built connectors to scientific literature, clinical trial databases and market intelligence feeds.
3. Roadmap for Additional Agentic AI Capabilities
Kala and Younet are actively developing four new features, including daily compressed publication reviews, real-time trigger-defined alerts, continuous IP filings monitoring, and dormant patent identification modules. These enhancements are designed to bolster recurring-revenue streams and solidify Kala's position as a strategic AI infrastructure partner for the life sciences sector.